Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001897612-25-000510·Immunome Inc.
Schedule 13G ownership disclosure
Immunome Inc
COMMON STOCK · CUSIP: 45257U108
Event date: 2025-10-31
- Filing-level shares
- 10,644,674
- Percent of class
- 12.2%
- T. Rowe Price Investment Management, Inc.
Shares: 10,644,674 · Class: 12.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001897612-25-000510
- Form type
- SCHEDULE 13G
- Filer
- Immunome Inc.
- CIK
- CIK 1472012
- Filed
- Nov 07, 2025
- Reporting period
- Oct 31, 2025
- Description
- Schedule 13G beneficial ownership